Low trough serum infliximab and antibodies to infliximab in smokers

Inflamm Bowel Dis. 2013 Mar;19(3):E35-6. doi: 10.1002/ibd.22928.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / blood
  • Anti-Inflammatory Agents, Non-Steroidal / immunology*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / blood
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use
  • Colitis, Ulcerative / blood
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / immunology
  • Crohn Disease / blood
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Smoking / adverse effects*
  • Smoking / immunology
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Infliximab